NO993396D0
(no )
1999-07-09
Kinolin- ig kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
DE60023982D1
(de )
2005-12-22
System zur Behandlung von benigner Prostatahyperplasie
NO20014560L
(no )
2001-09-19
Quinasoliner og terapautisk anvendelse derav
DE60033658D1
(de )
2007-04-12
Behandlung von prostata-krebs mit anti-erbb2 antikörpern
TR200103216T2
(tr )
2002-04-22
Pirimidinon bileşimleri
TR199801195T2
(xx )
1998-10-21
Tedavide yararl� kinolin ve kinozilin bile�ikleri.
AU3011299A
(en )
1999-10-18
Combination therapy for the treatment of benign prostatic hyperplasia
DE60009888T2
(de )
2005-04-21
Substituierte 3-cyano-[1.7], [1.5] und [1.8]naphthyridininhibitoren von tyrosin kinasen
ATE361075T1
(de )
2007-05-15
Pharmazeutische kombination zur behandlung von benigner prostatahyperplasie oder zur langzeitvorbeugung von akuter harnzurückhaltung
PT984777E
(pt )
2004-01-30
Piperazinas arilsubstituidas uteis no tratamento da hiperplasia benigna da prostata
ZA991315B
(en )
2000-11-20
Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.
ECSP982362A
(es )
1998-12-22
Compuestos de quinolina y quinazolina utiles en terapia
NO20005548L
(no )
2000-12-04
Mykobakterieinhibitorer
EA200401100A1
(ru )
2005-04-28
1α-ФТОР-25-ГИДРОКСИ-16,23E-ДИЕН-26,27-БИСГОМО-20-ЭПИХОЛЕКАЛЬЦИФЕРОЛ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ
ZA991319B
(en )
2000-11-20
Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
TR200003084T2
(tr )
2001-02-21
Paroxetine askorbat
GT199700003A
(es )
1998-07-10
Compuestos de quinolina y quinazolina utiles en terapia.
DE69807166D1
(de )
2002-09-19
Prostata-spezifische Antigen Inhibitore
GB9810895D0
(en )
1998-07-22
Combination therapy for the treatment of benign prostatic hyperplasia